Ontogenetic expression of spot 35 protein (calbindin-D28k) in human olfactory receptor neurons and its decrease in Alzheimer's disease patients

被引:15
作者
Yamagishi, M
Takami, S
Getchell, TV
机构
[1] UNIV KENTUCKY, COLL MED, DEPT PHYSIOL, LEXINGTON, KY 40536 USA
[2] UNIV KENTUCKY, COLL MED, DEPT SURG, DIV OTOLARYNGOL HEAD & NECK SURG, LEXINGTON, KY 40536 USA
[3] UNIV KENTUCKY, COLL MED, SANDERS BROWN CTR AGING, LEXINGTON, KY 40536 USA
关键词
Alzheimer's disease; calbindin-D28k; human olfactory mucosa; immunohistochemistry; neuron-specific enolase; olfactory marker protein; ontogeny; spot; 35; protein;
D O I
10.1177/000348949610500208
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Expression of a calcium-binding protein, spot 35 protein (S-35, calbindin-D28k), was investigated immunohistochemically in the human olfactory mucosa of patients who ranged in age from 16 weeks of fetal development to 98 years old, including some with Alzheimer's disease (AD). S-35 immunoreactivity was observed clearly in olfactory receptor neurons (ORNs) and olfactory nerve bundles that were identified previously with antibodies to olfactory marker protein (OMP) and neuron-specific enolase (NSE). Throughout all ages, the mean number of ORNs immunoreactive for OMP did not change significantly, whereas the mean number of NSE- and S-35-immunoreactive ORNs declined markedly in the postnatal infant, young, and old patients when compared with that of the prenatal fetuses. S-35-immunoreactive ORNs decreased significantly in AD patients when compared with AD control patients. These results indicate that ORNs in humans express S-35 and that there is an age-related trend in the expression of S-35. Furthermore, the marked decrease of S-35 expression in ORNs of AD patients suggests that cell excitability associated with calcium ions and cell protective function against overload of intracellular calcium ions decline in these patients.
引用
收藏
页码:132 / 139
页数:8
相关论文
共 44 条
[1]   DEVELOPMENTAL-CHANGES IN EXPRESSION OF A CALCIUM-BINDING PROTEIN (SPOT 35-CALBINDIN) IN THE NERVUS-TERMINALIS AND THE VOMERONASAL AND OLFACTORY RECEPTOR-CELLS [J].
ABE, H ;
WATANABE, M ;
KONDO, H .
ACTA OTO-LARYNGOLOGICA, 1992, 112 (05) :862-871
[2]   LOSS OF PARVALBUMIN-IMMUNOREACTIVE NEURONS FROM CORTEX IN ALZHEIMER-TYPE DEMENTIA [J].
ARAI, H ;
EMSON, PC ;
MOUNTJOY, CQ ;
CARASSCO, LH ;
HEIZMANN, CW .
BRAIN RESEARCH, 1987, 418 (01) :164-169
[3]   CALCIUM-BINDING PROTEINS IN THE NERVOUS-SYSTEM [J].
BAIMBRIDGE, KG ;
CELIO, MR ;
ROGERS, JH .
TRENDS IN NEUROSCIENCES, 1992, 15 (08) :303-308
[4]  
Doty R.L., 1991, SMELL TASTE HLTH DIS, P735
[5]   OLFACTORY MARKER PROTEIN DURING ONTOGENY - IMMUNOHISTOCHEMICAL LOCALIZATION [J].
FARBMAN, AI ;
MARGOLIS, FL .
DEVELOPMENTAL BIOLOGY, 1980, 74 (01) :205-215
[6]  
FELDMAN JI, 1991, LARYNGOSCOPE, V101, P1198
[7]  
FIRESTEIN S, 1993, CIBA F SYMP, V179, P115
[8]  
GETCHELL ML, 1994, OLFACTION TASTE, V11, P602
[9]   CHANGES IN CA2+-BINDING PROTEINS IN HUMAN NEURODEGENERATIVE DISORDERS [J].
HEIZMANN, CW ;
BRAUN, K .
TRENDS IN NEUROSCIENCES, 1992, 15 (07) :259-264
[10]   INTRACELLULAR CALCIUM-BINDING PROTEINS - MORE SITES THAN INSIGHTS [J].
HEIZMANN, CW ;
HUNZIKER, W .
TRENDS IN BIOCHEMICAL SCIENCES, 1991, 16 (03) :98-103